BIOMAT Database Logo BIOMAT Database Logo

Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin. 1991

N Kondo, and T Ozawa, and K Mushiake, and F Motoyoshi, and T Kameyama, and K Kasahara, and H Kaneko, and M Yamashina, and Y Kato, and T Orii
Department of Pediatrics, Gifu University School of Medicine, Japan.

The proliferative responses and the immunoglobulin production of peripheral blood mononuclear cells to pokeweed mitogen were dose-dependently suppressed by sulfonated intravenous immunoglobulin (IVIG), polyethylene glycol-treated IVIG, pH 4-treated IVIG, or human gamma-globulin, but they were not or only slightly suppressed by human serum albumin or pepsin-treated IVIG. Moreover, the suppression of immunoglobulin production by sulfonated IVIG, polyethylene glycol-treated IVIG, or pH 4-treated IVIG was seen in the cases in which B cells preincubated with IVIGs were cocultured with T cells and monocytes preincubated with or without IVIGs and in the cases in which monocytes preincubated with IVIGs were cocultured with T cells and B cells preincubated with or without IVIGs. However, in the cases in which only T cells were preincubated with IVIGs, immunoglobulin production was not suppressed. The suppression of the monocyte function by IVIGs tended to be less than the suppression of the B-cell function by IVIGs. Moreover, the suppression by IVIGs was blocked by anti-human IgG Fc. Our results suggest that IVIGs suppress the immunoglobulin production of lymphocytes through suppression of the B-cell function and the antigen presenting-cell function by attachment of IVIGs to Fc receptors of B-cell membranes and antigen presenting-cell membranes.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D011043 Pokeweed Mitogens Proteins isolated from the roots of the pokeweed, Phytolacca americana, that agglutinate some erythrocytes, stimulate mitosis and antibody synthesis in lymphocytes, and induce activation of plasma cells. Lectins, Pokeweed,Pokeweed Lectin,Pokeweed Lectins,Pokeweed Mitogen,Pokeweed Mitogen Isolectin,Isolectin, Pokeweed Mitogen,Lectin, Pokeweed,Mitogen Isolectin, Pokeweed,Mitogen, Pokeweed,Mitogens, Pokeweed
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000938 Antigen-Presenting Cells A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors. Accessory Cells, Immunologic,Antigen-Presenting Cell,Immunologic Accessory Cells,Accessory Cell, Immunologic,Cell, Immunologic Accessory,Cells, Immunologic Accessory,Immunologic Accessory Cell,Antigen Presenting Cell,Antigen Presenting Cells,Cell, Antigen-Presenting,Cells, Antigen-Presenting

Related Publications

N Kondo, and T Ozawa, and K Mushiake, and F Motoyoshi, and T Kameyama, and K Kasahara, and H Kaneko, and M Yamashina, and Y Kato, and T Orii
Suppression of immunoglobulin production of rat lymphocytes by bile acids.
November 1993, In vitro cellular & developmental biology. Animal,
N Kondo, and T Ozawa, and K Mushiake, and F Motoyoshi, and T Kameyama, and K Kasahara, and H Kaneko, and M Yamashina, and Y Kato, and T Orii
Intravenous immunoglobulin inhibits IgE production in human B lymphocytes.
September 1998, The Journal of allergy and clinical immunology,
N Kondo, and T Ozawa, and K Mushiake, and F Motoyoshi, and T Kameyama, and K Kasahara, and H Kaneko, and M Yamashina, and Y Kato, and T Orii
Immunoglobulin production by cultured human lymphocytes.
April 2000, Journal of immunological methods,
N Kondo, and T Ozawa, and K Mushiake, and F Motoyoshi, and T Kameyama, and K Kasahara, and H Kaneko, and M Yamashina, and Y Kato, and T Orii
Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use.
May 1990, Infection and immunity,
N Kondo, and T Ozawa, and K Mushiake, and F Motoyoshi, and T Kameyama, and K Kasahara, and H Kaneko, and M Yamashina, and Y Kato, and T Orii
Immunoglobulin and cytokine production by neonatal lymphocytes.
January 1991, Clinical and experimental immunology,
N Kondo, and T Ozawa, and K Mushiake, and F Motoyoshi, and T Kameyama, and K Kasahara, and H Kaneko, and M Yamashina, and Y Kato, and T Orii
Suppression of IgA production by lymphocytes induced by diphenylhydantoin.
January 1994, Journal of investigational allergology & clinical immunology,
N Kondo, and T Ozawa, and K Mushiake, and F Motoyoshi, and T Kameyama, and K Kasahara, and H Kaneko, and M Yamashina, and Y Kato, and T Orii
Delayed in vitro immunoglobulin production by cord lymphocytes.
March 1980, Pediatrics,
N Kondo, and T Ozawa, and K Mushiake, and F Motoyoshi, and T Kameyama, and K Kasahara, and H Kaneko, and M Yamashina, and Y Kato, and T Orii
Antigen-driven immunoglobulin production by human colostral lymphocytes.
March 1989, Pediatric research,
N Kondo, and T Ozawa, and K Mushiake, and F Motoyoshi, and T Kameyama, and K Kasahara, and H Kaneko, and M Yamashina, and Y Kato, and T Orii
Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin.
November 1994, Clinical immunology and immunopathology,
N Kondo, and T Ozawa, and K Mushiake, and F Motoyoshi, and T Kameyama, and K Kasahara, and H Kaneko, and M Yamashina, and Y Kato, and T Orii
Interleukin-16 inhibits immunoglobulin e production by B lymphocytes.
January 2007, International archives of allergy and immunology,
Copied contents to your clipboard!